BF
BMY.RT

BOK Financial’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

BOK Financial’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,681
Closed -$18K – 964
2020
Q4 		$18K Sell
25,681
-551
-2% -$1.17K ﹤0.01% 902
2020
Q3 		$59K Sell
26,232
-225
-0.9% -$643 ﹤0.01% 842
2020
Q2 		$95K Sell
26,457
-2,125
-7% -$7.67K ﹤0.01% 832
2020
Q1 		$109K Sell
28,582
-1,622
-5% -$5.34K ﹤0.01% 795
2019
Q4 		$91K Buy
+30,204
New +$78.5K ﹤0.01% 915

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

BOK Financial's BMY.RT Position: Q1 2021 in Review

BOK Financial sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 25,681 shares — an estimated $18K sold.

BOK Financial first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $109K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • BOK Financial reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • BOK Financial sold 25,681 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $18K.
  • BOK Financial first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • BOK Financial's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $109K in Q1 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on BOK Financial's 13F filing for Q1 2021, filed 21 Apr 2021.